Responses
Clinical/translational cancer immunotherapy
Original research
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma
Compose a Response to This Article
Other responses
No responses have been published for this article.
